|
Mar 13
|
High Growth Tech Stocks In The US Market March 2025
|
|
Mar 13
|
Emergent signs financial investment agreement with Swiss Rockets
|
|
Mar 13
|
Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
|
|
Mar 12
|
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
|
|
Mar 10
|
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
|
|
Mar 4
|
Emergent BioSolutions (EBS) Q4 2024 Earnings Call Transcript
|
|
Mar 4
|
Emergent BioSolutions Inc (EBS) Q4 2024 Earnings Call Highlights: Strategic Advancements Amid ...
|
|
Mar 3
|
Emergent Biosolutions (EBS) Q4 Earnings Top Estimates
|
|
Mar 3
|
Emergent Biosolutions: Q4 Earnings Snapshot
|
|
Mar 3
|
Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results
|
|
Mar 3
|
Emergent BioSolutions Inc. (NYSE:EBS) is favoured by institutional owners who hold 64% of the company
|
|
Feb 18
|
Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
|
|
Dec 30
|
Why Emergent BioSolutions Stock Blasted Higher Today
|